Zymeworks raises $61.5M, invests in Kairos

Antibody play Zymeworks Inc. (Vancouver, B.C.) raised US$61.5 million in a round co-led by new investors BDC Capital and Lumira Capital. Existing investors Eli Lilly and Co. (NYSE:LLY), Celgene

Read the full 294 word article

How to gain access

Continue reading with a
two-week free trial.